.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089132

« Back to Dashboard
NDA 089132 describes THEOLAIR-SR, which is a drug marketed by 3M and is included in four NDAs. Additional details are available on the THEOLAIR-SR profile page.

The generic ingredient in THEOLAIR-SR is theophylline. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for NDA: 089132

Tradename:
THEOLAIR-SR
Applicant:
3m
Ingredient:
theophylline
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength500MG
Approval Date:Jul 16, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc